Trevi Therapeutics (TRVI) Depreciation and Depletion (2018 - 2022)
Trevi Therapeutics' (TRVI) quarterly Depreciation and Depletion came in at $15000.0 in Q4 2022, up 25.0% year-on-year from $12000.0 in Q4 2021, and up 66.67% quarter-over-quarter from $9000.0 in Q3 2022.
Trevi Therapeutics (TRVI) Depreciation and Depletion (2018 - 2022) Analysis & Trends
Trevi Therapeutics' Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $15000.0 for Q4 2022.
- On a quarterly basis, Depreciation and Depletion rose 25.0% year-over-year to $15000.0 in Q4 2022; TTM through Dec 2022 was $43000.0, a 14.0% decrease from a year earlier, with the FY2025 full-year figure at $132000.0, up 40.43% from the prior year.
- Depreciation and Depletion climbed to $15000.0 in Q4 2022 per TRVI's latest filing, from $9000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $15000.0 in Q4 2022 and bottomed at $2000.0 in Q1 2018.
- The 5-year median for Depreciation and Depletion is $11000.0 (2019), against an average of $10100.0.
- Across the five-year window, Depreciation and Depletion jumped 350.0% in 2019 and sank 33.33% in 2022, its largest moves.
- Year by year, Depreciation and Depletion stood at $13000.0 in 2018, then slumped by 30.77% to $9000.0 in 2019, then soared by 44.44% to $13000.0 in 2020, then dropped by 7.69% to $12000.0 in 2021, then grew by 25.0% to $15000.0 in 2022.
- Per Business Quant, the three latest TRVI Depreciation and Depletion figures stand at $15000.0 (Q4 2022), $9000.0 (Q3 2022), and $8000.0 (Q2 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Trevi Therapeutics | 2.50 Bn | 2.50 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 15,000.00 |
| Dec 31, 2022 | 15,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 13,000.00 |
| Mar 31, 2021 | 13,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Sep 30, 2020 | 13,000.00 |
| Sep 30, 2020 | 13,000.00 |